ALLO Allogene Therapeutics, Inc.
Healthcare · Biological Products, (No Diagnostic Substances) · Market cap: $289.8M
–
Bought and sold by quarter, last 5 years
Open-market purchases and sales by this company's insiders, in dollars, last 5 years
| Quarter | Bought | Sold |
|---|---|---|
| 2022-Q1 | $2.1M | $442.6K |
| 2022-Q2 | $0 | $225.1K |
| 2022-Q3 | $0 | $298.1K |
| 2022-Q4 | $0 | $42.2K |
| 2023-Q1 | $0 | $41.7K |
| 2023-Q2 | $0 | $0 |
| 2023-Q3 | $0 | $42.9K |
| 2023-Q4 | $0 | $50.3K |
| 2024-Q1 | $684 | $0 |
| 2024-Q2 | $5.0M | $68.7K |
| 2024-Q3 | $0 | $0 |
| 2024-Q4 | $0 | $39.8K |
| 2025-Q1 | $0 | $336.1K |
| 2025-Q2 | $0 | $65.9K |
| 2025-Q3 | $0 | $0 |
| 2025-Q4 | $0 | $47.3K |
| 2026-Q1 | $0 | $534.1K |
| 2026-Q2 | $0 | $22.1K |
| 2026-Q3 | $0 | $63.0K |
| 2026-Q4 | $0 | $48.7K |
Bought$7.1M4 buy days
Sold$2.4M48 sell days
Net insider flow+$4.8Mnet buying · 5 years
Latest trade2026-10-21Parker Geoffrey M.
| Date | Side | Insider | Role | Shares | Avg price | Value | Trades |
|---|---|---|---|---|---|---|---|
| 2026-10-21 | Sell | Parker Geoffrey M. | CFO | 36,342 | $1.34 | $48.7K | 1 |
| 2026-08-21 | Sell | Douglas Earl Martin | General counsel | 29,697 | $2.12 | $63.0K | 1 |
| 2026-04-21 | Sell | Yoshiyama Annie | EVP / SVP | 9,586 | $2.31 | $22.1K | 1 |
| 2026-03-31 | Sell | Beneski Benjamin Machinas | Other C-suite | 2,867 | $2.50 | $7.2K | 1 |
| 2026-03-16 | Sell | Chang David D | CEO | 47,763 | $2.47 | $118.0K | 1 |
| 2026-03-16 | Sell | Beneski Benjamin Machinas | Other C-suite | 4,835 | $2.47 | $11.9K | 1 |
| 2026-03-02 | Sell | Beneski Benjamin Machinas | Other C-suite | 7,132 | $2.60 | $18.5K | 1 |
| 2026-02-02 | Sell | Chang David D | CEO | 95,269 | $1.80 | $171.5K | 1 |
| 2026-02-02 | Sell | Roberts Zachary | EVP / SVP | 35,700 | $1.77 | $63.2K | 1 |
| 2026-02-02 | Sell | Parker Geoffrey M. | CFO | 24,001 | $1.76 | $42.2K | 1 |
| 2026-02-02 | Sell | Douglas Earl Martin | General counsel | 22,900 | $1.76 | $40.3K | 1 |
| 2026-02-02 | Sell | Beneski Benjamin Machinas | Other C-suite | 7,549 | $1.73 | $13.1K | 1 |
| 2026-02-02 | Sell | Yoshiyama Annie | EVP / SVP | 4,167 | $1.72 | $7.2K | 1 |
| 2026-01-21 | Sell | Roberts Zachary | EVP / SVP | 26,269 | $1.56 | $41.0K | 1 |
| 2025-11-17 | Sell | Beneski Benjamin Machinas | Other C-suite | 786 | $1.22 | $959 | 1 |
| 2025-10-21 | Sell | Parker Geoffrey M. | CFO | 36,744 | $1.26 | $46.3K | 1 |
| 2025-06-10 | Sell | MESSEMER DEBORAH M. | Director | 36,885 | $1.42 | $52.4K | 1 |
| 2025-04-21 | Sell | Yoshiyama Annie | EVP / SVP | 9,601 | $1.41 | $13.5K | 1 |
| 2025-03-14 | Sell | Chang David D | CEO | 46,668 | $1.96 | $91.5K | 1 |
| 2025-03-14 | Sell | Beneski Benjamin Machinas | Other C-suite | 5,488 | $1.98 | $10.9K | 1 |
| 2025-02-18 | Sell | MESSEMER DEBORAH M. | Director | 13,313 | $2.43 | $32.4K | 1 |
| 2025-02-03 | Sell | Chang David D | CEO | 46,003 | $1.68 | $77.3K | 1 |
| 2025-02-03 | Sell | Roberts Zachary | EVP / SVP | 18,832 | $1.70 | $32.0K | 1 |
| 2025-02-03 | Sell | MOORE TIMOTHY L. | Other C-suite | 14,746 | $1.71 | $25.2K | 1 |
| 2025-02-03 | Sell | Douglas Earl Martin | General counsel | 6,404 | $1.71 | $11.0K | 1 |
| 2025-02-03 | Sell | Parker Geoffrey M. | CFO | 4,361 | $1.73 | $7.5K | 1 |
| 2025-01-21 | Sell | Roberts Zachary | EVP / SVP | 27,199 | $1.78 | $48.4K | 1 |
| 2024-12-09 | Sell | MESSEMER DEBORAH M. | Director | 9,136 | $2.18 | $19.9K | 1 |
| 2024-12-05 | Sell | Humer Franz B | Director | 9,221 | $2.16 | $19.9K | 1 |
| 2024-06-18 | Sell | MESSEMER DEBORAH M. | Director | 18,641 | $2.28 | $42.5K | 1 |
| 2024-05-30 | Sell | Humer Franz B | Director | 11,200 | $2.34 | $26.2K | 1 |
| 2024-05-16 | Buy | Belldegrun Arie | Director | 1,724,137 | $2.90 | $5.0M | 1 |
| 2024-01-30 | Buy | Parker Geoffrey M. | CFO | 190 | $3.60 | $684 | 1 |
| 2023-12-18 | Sell | MESSEMER DEBORAH M. | Director | 18,640 | $2.70 | $50.3K | 1 |
| 2023-08-07 | Sell | Mayo Stephen | Director | 10,000 | $4.29 | $42.9K | 1 |
| 2023-02-13 | Sell | Bhavnagri Veer | General counsel | 3,000 | $6.85 | $20.6K | 1 |
| 2023-01-17 | Sell | Bhavnagri Veer | General counsel | 3,000 | $7.04 | $21.1K | 1 |
| 2022-12-15 | Sell | Bhavnagri Veer | General counsel | 5,602 | $7.53 | $42.2K | 1 |
| 2022-08-12 | Sell | WITTE OWEN N. | Director | 5,000 | $17.25 | $86.2K | 1 |
| 2022-08-11 | Sell | WITTE OWEN N. | Director | 10,000 | $16.50 | $165.0K | 1 |
| 2022-08-02 | Sell | Amado Rafael | Other C-suite | 2,000 | $11.97 | $23.9K | 1 |
| 2022-07-05 | Sell | Amado Rafael | Other C-suite | 2,000 | $11.44 | $22.9K | 1 |
| 2022-06-22 | Sell | WITTE OWEN N. | Director | 10,000 | $11.76 | $117.6K | 1 |
| 2022-06-21 | Sell | Amado Rafael | Other C-suite | 2,000 | $11.18 | $22.4K | 1 |
| 2022-05-19 | Sell | Amado Rafael | Other C-suite | 11,500 | $7.40 | $85.1K | 1 |
| 2022-03-15 | Sell | Chang David D | CEO | 23,648 | $7.65 | $180.9K | 1 |
| 2022-03-15 | Sell | SCHMIDT ERIC THOMAS | CFO | 11,469 | $7.63 | $87.5K | 1 |
| 2022-03-15 | Sell | Bhavnagri Veer | General counsel | 8,849 | $7.68 | $68.0K | 1 |
| 2022-03-15 | Sell | MOORE ALISON | Other C-suite | 8,698 | $7.63 | $66.4K | 1 |
| 2022-03-15 | Sell | Amado Rafael | Other C-suite | 5,169 | $7.71 | $39.9K | 1 |
| 2022-01-12 | Buy | Belldegrun Arie | Director | 155,039 | $12.60 | $2.0M | 1 |
| 2022-01-12 | Buy | Kazam Joshua A | Director | 15,000 | $12.60 | $189.0K | 1 |
Who the insiders are, last 5 years
Everyone who bought or sold this company's shares on the open market in the last 5 years, biggest first.
| Insider | Role | Bought | Sold | Last trade |
|---|---|---|---|---|
| Belldegrun Arie | Director | $7.0M | $0 | 2024-05-16 |
| Chang David D | CEO | $0 | $639.1K | 2026-03-16 |
| WITTE OWEN N. | Director | $0 | $368.8K | 2022-08-12 |
| MESSEMER DEBORAH M. | Director | $0 | $197.5K | 2025-06-10 |
| Amado Rafael | Other C-suite | $0 | $194.1K | 2022-08-02 |
| Kazam Joshua A | Director | $189.0K | $0 | 2022-01-12 |
| Roberts Zachary | EVP / SVP | $0 | $184.6K | 2026-02-02 |
| Bhavnagri Veer | General counsel | $0 | $151.8K | 2023-02-13 |
| Parker Geoffrey M. | CFO | $684 | $144.8K | 2026-10-21 |
| Douglas Earl Martin | General counsel | $0 | $114.2K | 2026-08-21 |
| SCHMIDT ERIC THOMAS | CFO | $0 | $87.5K | 2022-03-15 |
| MOORE ALISON | Other C-suite | $0 | $66.4K | 2022-03-15 |
| Beneski Benjamin Machinas | Other C-suite | $0 | $62.5K | 2026-03-31 |
| Humer Franz B | Director | $0 | $46.1K | 2024-12-05 |
| Mayo Stephen | Director | $0 | $42.9K | 2023-08-07 |
| Yoshiyama Annie | EVP / SVP | $0 | $42.8K | 2026-04-21 |
| MOORE TIMOTHY L. | Other C-suite | $0 | $25.2K | 2025-02-03 |
Past buying clusters
A cluster is a run of purchases by three or more insiders. Returns are the stock's return minus its benchmark's (IWM for small companies, SPY otherwise), from the first open after the run became a cluster. Past results, not a forecast.
| Window | Insiders | Total | Score | 21 days vs benchmark | 63 days vs benchmark | 126 days vs benchmark | Status |
|---|---|---|---|---|---|---|---|
| 2018-10-15 | 6 | $18.8M | 56 | +27.4% (+30.3% raw) | +26.3% (+27.4% raw) | +15.4% (+22.4% raw) | closed |
Yahoo Finance data, delayed, loaded through this server. Informational only; not investment advice.